|
n (%)
|
115 (52.3)
|
105 (47.7)
| |
|
Sex [n (%)]
| | |
0.099
|
|
Male
|
76 (66.1)
|
57 (54.3)
| |
|
Female
|
39 (33.9)
|
48 (45.7)
| |
|
Age [years, mean (SD)]
|
47.5 (11.3)
|
43.8 (11.5)
|
0.017
|
|
Duration of HIV infection [years, median (IR)]
|
9 (5)
|
6 (6)
|
0.001
|
|
cART [years, median (IR)]
|
8 (5)
|
5 (5.5)
|
< 0.001
|
|
Weight [Kg, mean (SD)]
|
64.1 (12.8)
|
73.9 (12.6)
|
< 0.001
|
|
Height [m, mean (SD)]
|
1.7 (0.1)
|
1.7 (0.1)
|
0.765
|
|
BMI [(kg/m2), mean (SD)]
|
23.6 (3.8)
|
27.2 (4.5)
|
< 0.001
|
|
Waist circumference [cm, mean (SD)]
|
88.4 (10.8)
|
95.1 (12.1)
|
< 0.001
|
|
CD4 cell count [cells/mm3, median (IR)]
|
554 (385)
|
479 (300)
|
0.238
|
|
HIV RNA (<50) [n (%)]
|
100 (100)
|
92 (100)
| |
|
Hepatitis C co-infection [n (%)]
|
34 (29.8)
|
30 (29.4)
|
0.999
|
|
Hypertension [n (%)]
|
45 (39.1)
|
23 (21.9)
|
0.009
|
|
HIV risk factor [n (%)]
| | |
0.162
|
|
Intravenous drug user
|
1 (25)
|
3 (15.8)
| |
|
Homosexual contact
|
0 (0)
|
2 (10.5)
| |
|
Heterosexual contact
|
2 (50)
|
14 (73.7)
| |
|
Others
|
1 (25)
|
0 (0)
| |
|
CDC clinical categories [n (%)]
| | |
0.389
|
|
A
|
63 (54.8)
|
56 (53.3)
| |
|
B
|
1 (0.9)
|
4 (3.8)
| |
|
C
|
51 (44.3)
|
45 (42.9)
| |
|
ART [n (%)]
| | | |
|
IP
|
61 (53)
|
62 (59)
|
0.447
|
|
NNRTI
|
55 (47.8)
|
47 (44.8)
|
0.749
|
|
NRTI
|
113 (98.3)
|
97 (92.4)
|
0.051
|
|
Smoking history [n (%)]
| | |
0.032
|
|
Never
|
38 (33.3)
|
53 (50.5)
| |
|
Current
|
56 (49.1)
|
36 (34.3)
| |
|
Former
|
20 (17.5)
|
16 (15.2)
| |
|
Total cholesterol [mg/dL, mean (SD)]
|
221.9 (53.2)
|
227.8 (57.8)
|
0.433
|
|
LDL- cholesterol [mg/dL, mean (SD)]
|
129.4 (48.1)
|
140 (45.4)
|
0.097
|
|
HDL- cholesterol [mg/dL, mean (SD)]
|
46.5 (14.8)
|
49.5 (13.3)
|
0.123
|
|
Triglycerides [mg/dL, median (IR)]
|
215.5 (214.5)
|
171 (154)
|
0.007
|
|
Statin use [n (%)]
|
33 (28.7)
|
13 (12.4)
|
0.005
|
|
Fibrate use [n (%)]
|
41 (35.7)
|
24 (22.9)
|
0.054
|
